Immunotherapy

Filter By:

Dendritic cells alert the immune system to antigens and spur T cells into action.
Researchers find new mechanism to turn on cancer-killing T cells

A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.

Anne Kelley, BS, Kiranj Chaudagar, PhD, and Akash Patnaik, MD, PhD, MMSc
Personalized combination treatment turns on an immunometabolic switch to effectively control an aggressive form of prostate cancer
Depiction of cancerous areas in lungs
Simultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients
Michael R. Bishop, MD, presents the David Jonas Memorial Award to Hans Schreiber, MD, PhD.
Hans Schreiber receives inaugural Jonas Memorial Award for contributions to cellular immunotherapy
ASCO, equity and the future of cancer care: a Q&A with Dr. Everett Vokes
Image of Dr. Everett Vokes talking at ASCO meeting
Everett Vokes, MD, at ASCO 2022
ASCO Annual Meeting returns to Chicago, celebrates new progress in cancer
Jacelyn Walsh, CAR T-cell therapy patient
After years of treatment and relapses, CAR T-cell therapy helps leukemia patient
Example image of a biopsy (at the cellular level) with fluorescence labeling. Green represents immune cells. Red represents melanoma cells. Small yellow dots indicate RNA molecules of CXCL10. Blue represents the cell nucleus. A higher magnification view is shown at the bottom-left. Image adapted from: Reschke R, Yu J, Flood BA, et al. Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. Journal for ImmunoTherapy of Cancer 2021;9:e003521. doi: 10.1136/jitc-2021-003521
CXCL10: a promising marker for immunotherapy response in metastatic melanoma
CAR T-cell therapy patient Andrew Parker
CAR T-cell therapy recipient surpasses 5-year cancer-free mark
Cindy and Scott McIntyre. Scott is a CAR T-cell therapy patient
Six years after CAR T-cell therapy for lymphoma, patient still cancer-free
Adenocarcinoma arising in bronchiolar metaplasia. Case 274
Novel biomarker predicts how non-small cell lung cancer will progress after immunotherapy
New research leads to better outcomes for lung cancer patients
Female doctor showing lung scan to older female patient
A scientist looking into a microscope.
Researchers uncover inhibitory role of ‘Ter cells’ in cancer therapies
scientist in the cellular therapy laboratory, looking in microscope
Stem cell transplant team looks inward to improve survival rates for patients
nanotechnology
New nanotechology design provides hope for personalized vaccination for treating cancer
Load More article cards